This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08495/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08495/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08495/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08495/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08495/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08495
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB08495 n14:DB08495
dcterms:title
4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
adms:identifier
n6:DB08495 n7:RTR n8:394488 n9:447362 n10:99444966
n3:IUPAC-Name
n4:271B5DB1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5DB7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5DB6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5DB3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5DB4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5DB5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5DAF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5DB0-363D-11E5-9242-09173F13E4C5 n4:271B5DAD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5DAE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5DBD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5DBE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5DB8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5DB9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5DBB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5DBA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5DBC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5DC3-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5DC5-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5DC6-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5DC2-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5DC1-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5DC4-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5DB2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5DBF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5DC0-363D-11E5-9242-09173F13E4C5